furosemide has been researched along with candesartan in 14 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 7 (50.00) | 29.6817 |
2010's | 7 (50.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Ahlin, G; Artursson, P; Bergström, CA; Gustavsson, L; Karlsson, J; Larsson, R; Matsson, P; Norinder, U; Pedersen, JM | 1 |
Fisk, L; Greene, N; Naven, RT; Note, RR; Patel, ML; Pelletier, DJ | 1 |
Ekins, S; Williams, AJ; Xu, JJ | 1 |
Artursson, P; Haglund, U; Karlgren, M; Kimoto, E; Lai, Y; Norinder, U; Vildhede, A; Wisniewski, JR | 1 |
Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K | 1 |
Bell, PD; Kovács, G; Peti-Peterdi, J; Rosivall, L | 1 |
Brown, NJ; Kumar, S; Murphey, LJ; Sawathiparnich, P; Vaughan, DE | 1 |
Briggs, JP; Chen, L; Huang, YG; Kim, SM; Mizel, D; Schnermann, J | 1 |
Castrop, H; Hansen, PB; Oppermann, M; Schnermann, J | 1 |
Briggs, JP; Chen, L; Faulhaber-Walter, R; Huang, Y; Kim, SM; Mizel, D; Oppermann, M; Schnermann, J | 1 |
Ecelbarger, CM; Hu, X; Madala Halagappa, VK; Riazi, S; Tiwari, S | 1 |
Hosoya, T; Kuriyama, S; Otsuka, Y; Sugano, N; Ueda, H; Yamada, T; Yoshizawa, T | 1 |
Hanawa, H; Kobayashi, D; Kuroda, T; Murakami, S; Nakano, M; Narita, I; Oda, M; Wada, Y | 1 |
Akpek, M; Kaya, EG; Kaya, MG; Lam, YY; Sarli, B; Topsakal, R | 1 |
1 review(s) available for furosemide and candesartan
Article | Year |
---|---|
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk | 2016 |
2 trial(s) available for furosemide and candesartan
Article | Year |
---|---|
Effect of combined AT1 receptor and aldosterone receptor antagonism on plasminogen activator inhibitor-1.
Topics: Adult; Angiotensin Receptor Antagonists; Benzimidazoles; Biphenyl Compounds; Diuretics; Electrolytes; Female; Fibrinolysis; Furosemide; Hemodynamics; Humans; Male; Mineralocorticoid Receptor Antagonists; Plasminogen Activator Inhibitor 1; Potassium Chloride; Receptor, Angiotensin, Type 1; Renin-Angiotensin System; Single-Blind Method; Spironolactone; Tetrazoles | 2003 |
Tenascin-C as predictor of left ventricular remodeling and mortality in patients with dilated cardiomyopathy.
Topics: Aged; Antihypertensive Agents; Benzimidazoles; Biphenyl Compounds; Carbazoles; Cardiomyopathy, Dilated; Carvedilol; Drug Therapy, Combination; Echocardiography; Female; Furosemide; Heart Function Tests; Hong Kong; Humans; Male; Predictive Value of Tests; Prognosis; Propanolamines; Ramipril; Spironolactone; Survival Rate; Tenascin; Tetrazoles; Turkey; Ventricular Remodeling | 2013 |
11 other study(ies) available for furosemide and candesartan
Article | Year |
---|---|
Structural requirements for drug inhibition of the liver specific human organic cation transport protein 1.
Topics: Cell Line; Computer Simulation; Drug Design; Gene Expression Profiling; Humans; Hydrogen Bonding; Liver; Molecular Weight; Organic Cation Transporter 1; Pharmaceutical Preparations; Predictive Value of Tests; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger; Structure-Activity Relationship | 2008 |
Developing structure-activity relationships for the prediction of hepatotoxicity.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Humans; Structure-Activity Relationship; Tetracyclines; Thiophenes | 2010 |
A predictive ligand-based Bayesian model for human drug-induced liver injury.
Topics: Bayes Theorem; Chemical and Drug Induced Liver Injury; Humans; Ligands | 2010 |
Classification of inhibitors of hepatic organic anion transporting polypeptides (OATPs): influence of protein expression on drug-drug interactions.
Topics: Atorvastatin; Biological Transport; Drug Interactions; Estradiol; Estrone; HEK293 Cells; Heptanoic Acids; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; In Vitro Techniques; Least-Squares Analysis; Liver; Liver-Specific Organic Anion Transporter 1; Models, Molecular; Multivariate Analysis; Organic Anion Transporters; Organic Anion Transporters, Sodium-Independent; Protein Isoforms; Pyrroles; Solute Carrier Organic Anion Transporter Family Member 1B3; Structure-Activity Relationship; Transfection | 2012 |
Angiotensin II directly stimulates macula densa Na-2Cl-K cotransport via apical AT(1) receptors.
Topics: Angiotensin II; Angiotensin Receptor Antagonists; Animals; Antihypertensive Agents; Benzimidazoles; Biological Transport; Biphenyl Compounds; Cytosol; Diuretics; Furosemide; Imidazoles; Kidney Glomerulus; Microscopy, Fluorescence; Pyridines; Rabbits; Receptor, Angiotensin, Type 1; Receptor, Angiotensin, Type 2; Receptors, Angiotensin; Sodium; Sodium Chloride; Sodium-Potassium-Chloride Symporters; Tetrazoles; Vasoconstrictor Agents | 2002 |
Low plasma renin and reduced renin secretory responses to acute stimuli in conscious COX-2-deficient mice.
Topics: Adrenergic beta-Agonists; Angiotensin II Type 1 Receptor Blockers; Angiotensin-Converting Enzyme Inhibitors; Animals; Benzimidazoles; Biphenyl Compounds; Blood Pressure; Cells, Cultured; Cyclooxygenase 2; Diet, Sodium-Restricted; Diuretics; Enalapril; Furosemide; Isoproterenol; Juxtaglomerular Apparatus; Mice; Mice, Inbred C57BL; Mice, Knockout; Renin; Reverse Transcriptase Polymerase Chain Reaction; RNA; Telemetry; Tetrazoles | 2007 |
Vasodilatation of afferent arterioles and paradoxical increase of renal vascular resistance by furosemide in mice.
Topics: Angiotensin II Type 1 Receptor Blockers; Animals; Arterioles; Benzimidazoles; Biphenyl Compounds; Blood Pressure; Cyclooxygenase Inhibitors; Diuretics; Dose-Response Relationship, Drug; Furosemide; Indomethacin; Kidney Tubules; Male; Mice; Mice, Inbred C57BL; Prostaglandins; Renal Circulation; Sodium Potassium Chloride Symporter Inhibitors; Sodium-Potassium-Chloride Symporters; Solute Carrier Family 12, Member 2; Tetrazoles; Urodynamics; Vascular Resistance; Vasodilation | 2007 |
Regulation of renin secretion and expression in mice deficient in beta1- and beta2-adrenergic receptors.
Topics: Aldosterone; Angiotensin II Type 1 Receptor Blockers; Angiotensin-Converting Enzyme Inhibitors; Animals; Benzimidazoles; Biphenyl Compounds; Captopril; Dose-Response Relationship, Drug; Furosemide; Mice; Mice, Knockout; Osmolar Concentration; Receptors, Adrenergic, beta-1; Receptors, Adrenergic, beta-2; Renin; RNA, Messenger; Sodium Chloride, Dietary; Tetrahydroisoquinolines; Tetrazoles | 2007 |
Chronic candesartan alters expression and activity of NKCC2, NCC, and ENaC in the obese Zucker rat.
Topics: Amiloride; Angiotensin II; Angiotensin II Type 1 Receptor Blockers; Animals; Benzimidazoles; Biphenyl Compounds; Blood Pressure; Blotting, Western; Diuretics; Epithelial Sodium Channels; Furosemide; Hypertrophy; Kidney Tubules, Proximal; Male; Obesity; Rats; Rats, Zucker; Receptor, Angiotensin, Type 1; Receptors, Drug; Renin; Sodium-Hydrogen Exchanger 3; Sodium-Hydrogen Exchangers; Sodium-Phosphate Cotransporter Proteins, Type IIb; Sodium-Potassium-Chloride Symporters; Solute Carrier Family 12, Member 1; Solute Carrier Family 12, Member 3; Symporters; Tetrazoles | 2008 |
Augmented antihypertensive effect of a fixed combination formula of candesartan and hydrochlorothiazide combined with furosemide in a patient on peritoneal dialysis.
Topics: Adult; Angiotensin II Type 1 Receptor Blockers; Antihypertensive Agents; Benzimidazoles; Biphenyl Compounds; Diabetic Nephropathies; Diuretics; Drug Therapy, Combination; Female; Furosemide; Humans; Hydrochlorothiazide; Hypertension; Peritoneal Dialysis; Tetrazoles | 2011 |
Cardiac AA amyloidosis in a patient with rheumatoid arthritis and systemic sclerosis: the therapeutic potential of biological reagents.
Topics: Aged; Amyloidosis; Antibodies, Antinuclear; Antirheumatic Agents; Arthritis, Rheumatoid; Benzimidazoles; Biphenyl Compounds; Carbazoles; Carvedilol; Drug Therapy, Combination; Dyspnea; Etanercept; Female; Furosemide; Glucocorticoids; Hand; Heart Failure; Humans; Immunoglobulin G; Lung Diseases, Interstitial; Natriuretic Peptide, Brain; Propanolamines; Radiography; Receptors, Tumor Necrosis Factor; Rheumatoid Factor; Ribonucleosides; Scleroderma, Systemic; Spironolactone; Sulfasalazine; Tetrazoles; Treatment Outcome | 2011 |